Pharmacists use High-Tech monitors to fight prediabetes

NCT ID NCT07529366

Recruiting now Knowledge-focused Sponsor: University of South Florida Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study is testing whether a pharmacist-led program that uses continuous glucose monitors (CGMs) can help people with prediabetes better control their blood sugar and make healthier choices. About 40 adults with prediabetes will wear a CGM for 12 weeks and receive guidance from a pharmacist. Researchers will compare their blood sugar changes to a similar group from the past who did not use a CGM.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexcom Stelo continuous glucose monitor (CGM) device
What this could lead to: If successful, this could show that pharmacist-guided CGM use helps people with prediabetes lower their blood sugar and adopt healthier lifestyles.
What could go wrong: This is a small, early observational study with only 40 participants, so results may not apply widely. The CGM device is not a treatment itself, and lifestyle changes may not be sustained long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Health Behavior prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREDIABETES

Contacts and locations

Locations

USF Health Department of Family Medicine - Morsani Center for Advanced Health Care
RECRUITING

Tampa, Florida, 33612, United States
USF Health Department of Family Medicine - University Partnership Center
RECRUITING

Tampa, Florida, 33613, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.